CN113234719B - 检测线粒体膜电势的可遗传荧光探针及其应用 - Google Patents

检测线粒体膜电势的可遗传荧光探针及其应用 Download PDF

Info

Publication number
CN113234719B
CN113234719B CN202110649309.3A CN202110649309A CN113234719B CN 113234719 B CN113234719 B CN 113234719B CN 202110649309 A CN202110649309 A CN 202110649309A CN 113234719 B CN113234719 B CN 113234719B
Authority
CN
China
Prior art keywords
fluorescent probe
membrane potential
mitochondrial membrane
fluorescent
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110649309.3A
Other languages
English (en)
Other versions
CN113234719A (zh
Inventor
黄增益
张子元
王虹
任肃霞
程志
刘德一
徐超英
谭欣
谭力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Medical University
Original Assignee
Chongqing Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Medical University filed Critical Chongqing Medical University
Priority to CN202110649309.3A priority Critical patent/CN113234719B/zh
Publication of CN113234719A publication Critical patent/CN113234719A/zh
Application granted granted Critical
Publication of CN113234719B publication Critical patent/CN113234719B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432Quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明公开了一种检测线粒体膜电势的可遗传荧光探针及其应用,该荧光探针是由PINK1基因截短片段和荧光蛋白基因融合所得,最为优选的PINK1基因截短片段为SEQ IDNO.1所示的野生型PINK1基因序列的1‑390bp。本发明所提供的荧光探针具有制备方法简单,易储存,生物毒性低等优点;基于可遗传的特点,该线粒体膜电势探针应用面广泛,结合现代成像技术,可以快速灵敏的对目标细胞、组织、器官甚至是生命体的线粒体膜电势进行准确测量。

Description

检测线粒体膜电势的可遗传荧光探针及其应用
技术领域
本发明属于细胞生物学领域,具体涉及一种检测线粒体膜电势的可遗传荧光探针及其应用。
背景技术
线粒体通过氧化呼吸链来合成ATP。在氧化呼吸链中,电子由NADH,FADH2递氢体传递到呼吸链复合物,同时将质子主动运输到内膜外。内膜内外质子浓度梯度和跨膜电位差所储存的电化学势能即为线粒体膜电势,发挥着促使质子返回线粒体内膜,推动ATP合成酶合成ATP的作用。
线粒体膜电势的维持是健康线粒体发挥正常功能从而维护细胞稳态的必要条件。膜电势的异常不仅会阻碍氧化磷酸化的正常进行,还可以激活线粒体自噬通路来消除功能异常的线粒体。在多种疾病和病理情况下均检测到细胞中线粒体膜电势的异常,因此对线粒体膜电势变化的检测有助于我们加深对于疾病发展的进一步理解,有着重要的科学意义和现实意义。
对于线粒体膜电势的检测主要有电化学方法和荧光成像等方法。电化学方法主要是利用微电极准确测量线粒体内膜内外的电势差,具有很好的准确性。但由于线粒体体积小,难以精准的嵌入微电极,限制了电化学方法进行。荧光成像方法的主要原理是在细胞中线粒体膜电势发生改变后,其荧光染料在细胞中的荧光性质会发生一定的改变,从而根据荧光信号的改变来间接反映线粒体的膜电势。荧光染料对于线粒体膜电势的测量具有简单、方便、对细胞损伤较小等优点,因而被广泛应用于科学研究当中。目前,JC-1是常用于检测线粒体膜电势的荧光探针。正常线粒体膜电势情况下,JC-1在线粒体中呈现聚集态,发出橘红色的荧光,而在低线粒体膜电势的情况下,JC-1在线粒体中呈现单体态,发出绿色荧光,因此JC-1可通过荧光颜色的变化反映线粒体膜电势的变化。然而,作为可跨越线粒体膜的染料,外源添加JC-1等荧光染料对于线粒体具有潜在的影响。同时,目前的检测线粒体膜电势荧光成像方法不具有可遗传性,难以对疾病的全程,整体进行观测。因此,开发一种可遗传检测线粒体膜电势荧光探针是非常必要的。
发明内容
有鉴于此,本发明的目的在于提供一种检测线粒体膜电势的可遗传荧光探针;本发明的目的之二在于提供含有所述荧光探针的重组质粒;本发明的目的之三在于提供含有所述重组质粒的转化体;本发明的目的之四在于提供所述荧光探针检测线粒体膜电势的方法;本发明的目的之五在于提供所述荧光探针在检测线粒体膜电势降低中的应用;本发明的目的之六在于提供所述荧光探针在标记线粒体在活细胞中的分布中的应用。
为达到上述目的,本发明提供如下技术方案:
1、一种检测线粒体膜电势的可遗传荧光探针,所述荧光探针是由PINK1基因截短片段和荧光蛋白基因融合所得,所述PINK1基因截短片段为SEQ ID NO.1所示的野生型PINK1基因序列的1-390bp或1-240bp。
本发明中优选的,所述PINK1基因截短片段为SEQ ID NO.1所示的野生型PINK1基因序列的1-390bp。
本发明中优选的,所述荧光蛋白基因为红色荧光蛋白基因。
本发明中更为优选的,所述红色荧光蛋白基因的核苷酸序列如SEQ ID NO.4所示。
2、含有所述荧光探针的重组质粒。
本发明中优选的,所述重组质粒为将所述的荧光探针的核苷酸序列插入到pCMV载体或pcDNA载体的多克隆位点处。
3、含有所述重组质粒的转化体。
4、所述的荧光探针检测线粒体膜电势变化的方法,其特征在于:用含有所述荧光探针的重组质粒转染动物细胞或动物体,根据线粒体外膜上的荧光强度变化判断线粒体膜电势的变化。
5、所述荧光探针在检测线粒体膜电势降低中的应用。
6、所述荧光探针在标记线粒体在活细胞中的分布中的应用。
本发明的有益效果在于:本发明提供了一种检测线粒体膜电势可遗传荧光探针及其应用,该荧光探针是由PINK1基因截短片段和荧光蛋白基因融合所得,最为优选的PINK1基因截短片段为SEQ ID NO.1所示的野生型PINK1基因序列的1-390bp。本发明所提供的荧光探针可通过质粒转染等方式编入宿主基因组中从而具有可遗传性,而且该荧光探针在线粒体氧化磷酸化解偶联试剂处理两小时后即有明显的效应,在利用模式动物研究线粒体膜电势作用及应用领域具有极大的潜力;并且该荧光探针具有制备方法简单,易储存,生物毒性低等优点;基于可遗传的特点,该线粒体膜电势探针应用面广泛,结合现代成像技术,可以快速灵敏的对目标细胞、组织、器官甚至是生命体的线粒体膜电势进行准确测量。
附图说明
为了使本发明的目的、技术方案和有益效果更加清楚,本发明提供如下附图进行说明:
图1为重组载体pcDNA3.1(+)-PINK1-mRFP和pcDNA3.1(+)-TOM20-GFP共同转染Hela细胞后共定位图;
图2为重组载体pcDNA3.1(+)-gMPOR的基因序列图谱和质粒图谱。
具体实施方式
下面结合附图和具体实施例对本发明作进一步说明,以使本领域的技术人员可以更好的理解本发明并能予以实施,但所举实施例不作为对本发明的限定。
除非特别说明,下述实施例中使用的试剂原料为常规市购或商业途径获得的生化试剂原料,使用的实验仪器均为实验室常规仪器。除非特别说明,下述实施例中使用的方法和设备为本领域常规使用的方法和设备。
实施例1、野生型PINK1基因及重组质粒的获得
在NCBI上公布的人磷酸酶及张力蛋白同源物(PTEN)诱导的激酶1(PTEN-inducedkinase1,PINK1)基因的序列,如SEQ ID NO.1所示(Gene ID:65018),利用NCBI工具primerBLAST选择到特异性引物,具体引物序列如下:
PINK1-F:gaattcatggcggtgcgacaggcgctgg(SEQ ID NO.2);
PINK1-R:gcggccgctcacagggctgccctccatgag(SEQ ID NO.3)
在前向引物ATG前增加GAATTC(EcoR I酶切位点),在其反向引物终止密码子TGA后增加gcggccgc(Not I酶切位点),引物由北京华大基因科技有限公司合成所得。随后,利用PCR从HEK293T细胞的cDNA进行扩增获得野生型PINK1基因,之后用限制性内切酶EcoRI和Not I对野生型PINK1基因进行双酶切,同时,使用限制性内切酶EcoR I和Not I对pcDNA3.1(+)载体进行双酶切,使用凝胶纯化试剂盒将酶切产物纯化,并用T4连接酶将两个产物连接,将连接产物转入E.coli DH5α感受态细胞中,提取质粒,酶切鉴定,测序鉴定确定载体构建成功,命名为pcDNA3.1(+)-wtPINK1。
实施例2、红色荧光蛋白基因及重组质粒的获得
从实验室保存的质粒pcDNA3.1(+)-RFP中获取到如SEQ ID NO.4所示的红色荧光蛋白序列,在起始密码子ATG前增加gcggccgcggccacc(Not I酶切位点和Kozak序列),在终止密码子后增加TCTAGA(XbaI酶切位点),设计相应引物后,引物由北京华大基因科技有限公司合成所得,具体引物序列如下:
mRFP-F:gcggccgcGGCCACCatggcctcctccgaggacgt(SEQ ID NO.5);
mRFP-R:tctagattaggcgccggtggagtggc(SEQ ID NO.6);
随后,利用PCR从质粒pcDNA3.1(+)-RFP扩增获得红色荧光蛋白基因,之后用限制性内切酶Not I和Xba I对红色荧光蛋白基因进行双酶切,同时,使用限制性内切酶Not I和Xba I对pcDNA3.1(+)载体进行双酶切,使用凝胶纯化试剂盒将酶切产物纯化,并用T4连接酶将两个产物连接,将连接产物转入E.coli DH5α感受态细胞中,提取质粒,酶切鉴定,测序鉴定确定载体构建成功,命名为pcDNA3.1(+)-mRFP。
实施例3、检测线粒体膜电势可遗传荧光探针基因及重组质粒的获得
为了保留PINK1基因对于膜电势变化的灵敏度,同时去除PINK1对于线粒体自噬的介导能力,本发明通过去除PINK1基因(SEQ ID NO.1)480bp之后的核苷酸序列,即PINK1酶活性区域和C末端区域,从剩下的1-480bp核苷酸序列中,筛选出能够响应线粒体膜电势变化的最优PINK1 N端核苷酸序列。通过在起始密码子ATG前增加GAATTC(EcoR I酶切位点),在不同长度的PINK1 N端序列基因后增加gcggccgc(Not I酶切位点),引物由北京华大基因科技有限公司合成所得。随后,利用PCR从野生型PINK1基因处获得带有酶切位点的不同长度的PINK1 N端序列基因,之后用限制性内切酶EcoR I和Not I对不同长度PINK1 N端序列基因进行双酶切,同时,使用限制性内切酶EcoR I和Not I对pcDNA3.1(+)-mRFP载体进行双酶切,使用凝胶纯化试剂盒将酶切产物纯化,并用T4连接酶将两个产物连接,将连接产物转入E.coli DH5α感受态细胞中,提取质粒,酶切鉴定,送测序鉴定确定载体构建成功,载体命名为pcDNA3.1(+)-PINK1-mRFP。
pcDNA3.1(+)-TOM20-GFP重组质粒构建过程如下:从HEK293T细胞cDNA中扩增1-126bp TOM20序列(SEQ ID NO.7),该序列包含TOM20的线粒体引导序列,能够引导融合蛋白靶向线粒体,具体引物为:
TOM20-F:ccaagctggctagcgtttaaacttaagcttatggtgggtcggaacagcgc(SEQ IDNO.8);
TOM20-R:agctcctcgcccttgctcacGCCTGATGATCCACCTCCtcttcgttctcgaagcctgt(SEQ ID NO.9);
随后从实验室保存质粒pCDNA3.1(+)中扩增出GFP序列(SEQ ID NO.10),具体引物为:
GFP-F:acaggcttcgagaacgaagaGGAGGTGGATCATCAGGCgtgagcaagggcgaggagct(SEQID NO.11);
GFP-R:cgagcggccgcgaattcttacttgtacagctcgtccatgc(SEQ ID NO.12);
随后将1-126bp TOM20和GFP使用重叠PCR进行连接,之后使用限制性内切酶HindIII(AAGCTT)和EcoR I(GAATTC)对TOM20-GFP序列进行双酶切,同时,使用限制性内切酶Hind III和EcoR I对pCDNA3.1(+)载体进行双酶切,使用凝胶纯化试剂盒将酶切产物纯化,并用T4连接酶将两个产物连接,将连接产物转入E.coli DH5α感受态细胞中,提取质粒,酶切鉴定,送测序鉴定确定载体构建成功,载体命名为pcDNA3.1(+)-TOM20-GFP。
实施例4、不同长度的线粒体膜电势可遗传荧光探针基因对于膜电势改变的响应能力
分别将含有1-240bp、1-480bp、1-390bp的PINK1 N端核苷酸序列的重组载体pcDNA3.1(+)-PINK1-mRFP和指示线粒体pcDNA3.1(+)-TOM20-GFP重组质粒共同转染Hela细胞,结果如图1所示,图1中CTL为对照组,CCCP为处理组。对照组加入溶剂DMSO,处理组加入线粒体氧化磷酸化解偶联剂CCCP,其中CCCP能够携带质子穿越线粒体内膜,发挥降低线粒体膜电势的功能。在CCCP处理2h后终止反应,固定,DAPI染色,加入抗荧光淬灭剂后,使用莱卡激光扫描共聚焦显微镜观察细胞线粒体。指示线粒体的绿色荧光蛋白可采用波长488nm激发,检测波段为绿光波段500-550nm;指示膜电势变化的红色荧光蛋白可采用波长510-550nm激发,检测波段为红光波段600-650nm;指示细胞核的DAPI可采用波长405nm激发,检测波段为410-450nm。以1-240bp和1-480bp PINK1 N端核苷酸序列为例,如图1所示,在对照组中,红色荧光分布在线粒体和细胞质中,和指示线粒体的绿色荧光有弱共定位;而在CCCP处理组中未出现明显的改变。而在1-390bp PINK1 N端序列中(gMPOR),对照组红色荧光分布在线粒体和细胞质中,和指示线粒体的绿色荧光有弱共定位,而在CCCP处理组中,红色荧光聚集在线粒体上,和指示线粒体的绿色荧光有强共定位。因此最终筛选得到了390bpPINK1 N端序列对于线粒体膜电势变化的响应最为明显,将筛选到的最优重组质粒命名为pcDNA3.1(+)-gMPOR,所述gMPOR的核苷酸序列为SEQ ID NO.13所示,氨基酸序列为SEQ IDNO.14所示,基因序列图谱和质粒图谱如图2所示。
以上所述实施例仅是为充分说明本发明而所举的较佳的实施例,本发明的保护范围不限于此。本技术领域的技术人员在本发明基础上所作的等同替代或变换,均在本发明的保护范围之内。本发明的保护范围以权利要求书为准。
序列表
<110> 重庆医科大学
<120> 检测线粒体膜电势的可遗传荧光探针及其应用
<160> 14
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1746
<212> DNA
<213> 人(Homo sapiens)
<400> 1
atggcggtgc gacaggcgct gggccgcggc ctgcagctgg gtcgagcgct gctgctgcgc 60
ttcacgggca agcccggccg ggcctacggc ttggggcggc cgggcccggc ggcgggctgt 120
gtccgcgggg agcgtccagg ctgggccgca ggaccgggcg cggagcctcg cagggtcggg 180
ctcgggctcc ctaaccgtct ccgcttcttc cgccagtcgg tggccgggct ggcggcgcgg 240
ttgcagcggc agttcgtggt gcgggcctgg ggctgcgcgg gcccttgcgg ccgggcagtc 300
tttctggcct tcgggctagg gctgggcctc atcgaggaaa aacaggcgga gagccggcgg 360
gcggtctcgg cctgtcagga gatccaggca atttttaccc agaaaagcaa gccggggcct 420
gacccgttgg acacgagacg cttgcagggc tttcggctgg aggagtatct gatagggcag 480
tccattggta agggctgcag tgctgctgtg tatgaagcca ccatgcctac attgccccag 540
aacctggagg tgacaaagag caccgggttg cttccaggga gaggcccagg taccagtgca 600
ccaggagaag ggcaggagcg agctccgggg gcccctgcct tccccttggc catcaagatg 660
atgtggaaca tctcggcagg ttcctccagc gaagccatct tgaacacaat gagccaggag 720
ctggtcccag cgagccgagt ggccttggct ggggagtatg gagcagtcac ttacagaaaa 780
tccaagagag gtcccaagca actagcccct caccccaaca tcatccgggt tctccgcgcc 840
ttcacctctt ccgtgccgct gctgccaggg gccctggtcg actaccctga tgtgctgccc 900
tcacgcctcc accctgaagg cctgggccat ggccggacgc tgttcctcgt tatgaagaac 960
tatccctgta ccctgcgcca gtacctttgt gtgaacacac ccagcccccg cctcgccgcc 1020
atgatgctgc tgcagctgct ggaaggcgtg gaccatctgg ttcaacaggg catcgcgcac 1080
agagacctga aatccgacaa catccttgtg gagctggacc cagacggctg cccctggctg 1140
gtgatcgcag attttggctg ctgcctggct gatgagagca tcggcctgca gttgcccttc 1200
agcagctggt acgtggatcg gggcggaaac ggctgtctga tggccccaga ggtgtccacg 1260
gcccgtcctg gccccagggc agtgattgac tacagcaagg ctgatgcctg ggcagtggga 1320
gccatcgcct atgaaatctt cgggcttgtc aatcccttct acggccaggg caaggcccac 1380
cttgaaagcc gcagctacca agaggctcag ctacctgcac tgcccgagtc agtgcctcca 1440
gacgtgagac agttggtgag ggcactgctc cagcgagagg ccagcaagag accatctgcc 1500
cgagtagccg caaatgtgct tcatctaagc ctctggggtg aacatattct agccctgaag 1560
aatctgaagt tagacaagat ggttggctgg ctcctccaac aatcggccgc cactttgttg 1620
gccaacaggc tcacagagaa gtgttgtgtg gaaacaaaaa tgaagatgct ctttctggct 1680
aacctggagt gtgaaacgct ctgccaggca gccctcctcc tctgctcatg gagggcagcc 1740
ctgtga 1746
<210> 2
<211> 28
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 2
gaattcatgg cggtgcgaca ggcgctgg 28
<210> 3
<211> 30
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 3
gcggccgctc acagggctgc cctccatgag 30
<210> 4
<211> 678
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 4
atggcctcct ccgaggacgt catcaaggag ttcatgcgct tcaaggtgcg catggagggc 60
tccgtgaacg gccacgagtt cgagatcgag ggcgagggcg agggccgccc ctacgagggc 120
acccagaccg ccaagctgaa ggtgaccaag ggcggccccc tgcccttcgc ctgggacatc 180
ctgtcccctc agttccagta cggctccaag gcctacgtga agcaccccgc cgacatcccc 240
gactacttga agctgtcctt ccccgagggc ttcaagtggg agcgcgtgat gaacttcgag 300
gacggcggcg tggtgaccgt gacccaggac tcctccctgc aggacggcga gttcatctac 360
aaggtgaagc tgcgcggcac caacttcccc tccgacggcc ccgtaatgca gaagaagacc 420
atgggctggg aggcctccac cgagcggatg taccccgagg acggcgccct gaagggcgag 480
atcaagatga ggctgaagct gaaggacggc ggccactacg acgccgaggt caagaccacc 540
tacatggcca agaagcccgt gcagctgccc ggcgcctaca agaccgacat caagctggac 600
atcacctccc acaacgagga ctacaccatc gtggaacagt acgagcgcgc cgagggccgc 660
cactccaccg gcgcctaa 678
<210> 5
<211> 35
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 5
gcggccgcgg ccaccatggc ctcctccgag gacgt 35
<210> 6
<211> 26
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 6
tctagattag gcgccggtgg agtggc 26
<210> 7
<211> 126
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 7
atggtgggtc ggaacagcgc catcgccgcc ggtgtatgcg gggccctttt cattgggtac 60
tgcatctact tcgaccgcaa aagacgaagt gaccccaact tcaagaacag gcttcgagaa 120
cgaaga 126
<210> 8
<211> 50
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 8
ccaagctggc tagcgtttaa acttaagctt atggtgggtc ggaacagcgc 50
<210> 9
<211> 58
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 9
acaggcttcg agaacgaaga ggaggtggat catcaggcgt gagcaagggc gaggagct 58
<210> 10
<211> 735
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 10
ggaggtggat catcaggcgt gagcaagggc gaggagctgt tcaccggggt ggtgcccatc 60
ctggtcgagc tggacggcga cgtaaacggc cacaagttca gcgtgtccgg cgagggcgag 120
ggcgatgcca cctacggcaa gctgaccctg aagttcatct gcaccaccgg caagctgccc 180
gtgccctggc ccaccctcgt gaccaccctg acctacggcg tgcagtgctt cagccgctac 240
cccgaccaca tgaagcagca cgacttcttc aagtccgcca tgcccgaagg ctacgtccag 300
gagcgcacca tcttcttcaa ggacgacggc aactacaaga cccgcgccga ggtgaagttc 360
gagggcgaca ccctggtgaa ccgcatcgag ctgaagggca tcgacttcaa ggaggacggc 420
aacatcctgg ggcacaagct ggagtacaac tacaacagcc acaacgtcta tatcatggcc 480
gacaagcaga agaacggcat caaggtgaac ttcaagatcc gccacaacat cgaggacggc 540
agcgtgcagc tcgccgacca ctaccagcag aacaccccca tcggcgacgg ccccgtgctg 600
ctgcccgaca accactacct gagcacccag tccgccctga gcaaagaccc caacgagaag 660
cgcgatcaca tggtcctgct ggagttcgtg accgccgccg ggatcactct cggcatggac 720
gagctgtaca agtaa 735
<210> 11
<211> 58
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 11
acaggcttcg agaacgaaga ggaggtggat catcaggcgt gagcaagggc gaggagct 58
<210> 12
<211> 80
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 12
agcggccgcg aattcttact cggtcagtct tcttctcagc tcctcctcca gtctgctggg 60
cttgtacagc tcgtccatgc 80
<210> 13
<211> 1083
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 13
atggcggtgc gacaggcgct gggccgcggc ctgcagctgg gtcgagcgct gctgctgcgc 60
ttcacgggca agcccggccg ggcctacggc ttggggcggc cgggcccggc ggcgggctgt 120
gtccgcgggg agcgtccagg ctgggccgca ggaccgggcg cggagcctcg cagggtcggg 180
ctcgggctcc ctaaccgtct ccgcttcttc cgccagtcgg tggccgggct ggcggcgcgg 240
ttgcagcggc agttcgtggt gcgggcctgg ggctgcgcgg gcccttgcgg ccgggcagtc 300
tttctggcct tcgggctagg gctgggcctc atcgaggaaa aacaggcgga gagccggcgg 360
gcggtctcgg cctgtcagga gatccaggca gcggccgcgg ccaccatggc ctcctccgag 420
gacgtcatca aggagttcat gcgcttcaag gtgcgcatgg agggctccgt gaacggccac 480
gagttcgaga tcgagggcga gggcgagggc cgcccctacg agggcaccca gaccgccaag 540
ctgaaggtga ccaagggcgg ccccctgccc ttcgcctggg acatcctgtc ccctcagttc 600
cagtacggct ccaaggccta cgtgaagcac cccgccgaca tccccgacta cttgaagctg 660
tccttccccg agggcttcaa gtgggagcgc gtgatgaact tcgaggacgg cggcgtggtg 720
accgtgaccc aggactcctc cctgcaggac ggcgagttca tctacaaggt gaagctgcgc 780
ggcaccaact tcccctccga cggccccgta atgcagaaga agaccatggg ctgggaggcc 840
tccaccgagc ggatgtaccc cgaggacggc gccctgaagg gcgagatcaa gatgaggctg 900
aagctgaagg acggcggcca ctacgacgcc gaggtcaaga ccacctacat ggccaagaag 960
cccgtgcagc tgcccggcgc ctacaagacc gacatcaagc tggacatcac ctcccacaac 1020
gaggactaca ccatcgtgga acagtacgag cgcgccgagg gccgccactc caccggcgcc 1080
taa 1083
<210> 14
<211> 360
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 14
Met Ala Val Arg Gln Ala Leu Gly Arg Gly Leu Gln Leu Gly Arg Ala
1 5 10 15
Leu Leu Leu Arg Phe Thr Gly Lys Pro Gly Arg Ala Tyr Gly Leu Gly
20 25 30
Arg Pro Gly Pro Ala Ala Gly Cys Val Arg Gly Glu Arg Pro Gly Trp
35 40 45
Ala Ala Gly Pro Gly Ala Glu Pro Arg Arg Val Gly Leu Gly Leu Pro
50 55 60
Asn Arg Leu Arg Phe Phe Arg Gln Ser Val Ala Gly Leu Ala Ala Arg
65 70 75 80
Leu Gln Arg Gln Phe Val Val Arg Ala Trp Gly Cys Ala Gly Pro Cys
85 90 95
Gly Arg Ala Val Phe Leu Ala Phe Gly Leu Gly Leu Gly Leu Ile Glu
100 105 110
Glu Lys Gln Ala Glu Ser Arg Arg Ala Val Ser Ala Cys Gln Glu Ile
115 120 125
Gln Ala Ala Ala Ala Ala Thr Met Ala Ser Ser Glu Asp Val Ile Lys
130 135 140
Glu Phe Met Arg Phe Lys Val Arg Met Glu Gly Ser Val Asn Gly His
145 150 155 160
Glu Phe Glu Ile Glu Gly Glu Gly Glu Gly Arg Pro Tyr Glu Gly Thr
165 170 175
Gln Thr Ala Lys Leu Lys Val Thr Lys Gly Gly Pro Leu Pro Phe Ala
180 185 190
Trp Asp Ile Leu Ser Pro Gln Phe Gln Tyr Gly Ser Lys Ala Tyr Val
195 200 205
Lys His Pro Ala Asp Ile Pro Asp Tyr Leu Lys Leu Ser Phe Pro Glu
210 215 220
Gly Phe Lys Trp Glu Arg Val Met Asn Phe Glu Asp Gly Gly Val Val
225 230 235 240
Thr Val Thr Gln Asp Ser Ser Leu Gln Asp Gly Glu Phe Ile Tyr Lys
245 250 255
Val Lys Leu Arg Gly Thr Asn Phe Pro Ser Asp Gly Pro Val Met Gln
260 265 270
Lys Lys Thr Met Gly Trp Glu Ala Ser Thr Glu Arg Met Tyr Pro Glu
275 280 285
Asp Gly Ala Leu Lys Gly Glu Ile Lys Met Arg Leu Lys Leu Lys Asp
290 295 300
Gly Gly His Tyr Asp Ala Glu Val Lys Thr Thr Tyr Met Ala Lys Lys
305 310 315 320
Pro Val Gln Leu Pro Gly Ala Tyr Lys Thr Asp Ile Lys Leu Asp Ile
325 330 335
Thr Ser His Asn Glu Asp Tyr Thr Ile Val Glu Gln Tyr Glu Arg Ala
340 345 350
Glu Gly Arg His Ser Thr Gly Ala
355 360

Claims (9)

1.一种检测线粒体膜电势的可遗传荧光探针,其特征在于:所述荧光探针是由PINK1基因截短片段和荧光蛋白基因融合所得,所述PINK1基因截短片段为SEQ ID NO.1所示的野生型PINK1基因序列的1-390bp。
2.根据权利要求1所述的荧光探针,其特征在于:所述荧光蛋白基因为红色荧光蛋白基因。
3.根据权利要求2所述的荧光探针,其特征在于:所述红色荧光蛋白基因的核苷酸序列如SEQ ID NO.4所示。
4.含有权利要求1~3任一项所述的荧光探针的重组质粒。
5.根据权利要求4所述的重组质粒,其特征在于:所述重组质粒为将权利要求1~3任一项所述的荧光探针的核苷酸序列插入到pCMV载体或pcDNA载体的多克隆位点处。
6.含有权利要求4或5所述的重组质粒的转化体。
7.权利要求1~3任一项所述的荧光探针检测线粒体膜电势变化的方法,其特征在于:用含有权利要求1~3任一项所述的荧光探针的重组质粒转染动物细胞或动物体,根据线粒体外膜上的荧光强度变化判断线粒体膜电势的变化,所述方法用于非诊断目的。
8.权利要求1~3任一项所述的荧光探针在检测线粒体膜电势降低中的应用,所述应用为非诊断目的。
9.权利要求1~3任一项所述的荧光探针在标记线粒体在活细胞中的分布中的应用,所述应用为非诊断目的。
CN202110649309.3A 2021-06-08 2021-06-08 检测线粒体膜电势的可遗传荧光探针及其应用 Active CN113234719B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110649309.3A CN113234719B (zh) 2021-06-08 2021-06-08 检测线粒体膜电势的可遗传荧光探针及其应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110649309.3A CN113234719B (zh) 2021-06-08 2021-06-08 检测线粒体膜电势的可遗传荧光探针及其应用

Publications (2)

Publication Number Publication Date
CN113234719A CN113234719A (zh) 2021-08-10
CN113234719B true CN113234719B (zh) 2022-04-29

Family

ID=77139533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110649309.3A Active CN113234719B (zh) 2021-06-08 2021-06-08 检测线粒体膜电势的可遗传荧光探针及其应用

Country Status (1)

Country Link
CN (1) CN113234719B (zh)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108120836B (zh) * 2017-12-06 2020-08-14 大连理工大学 一种检测活细胞内Paxillin蛋白力传递的荧光生物探针
CN112162096A (zh) * 2020-03-05 2021-01-01 上海生物芯片有限公司 用于检测细胞线粒体自噬的双荧光蛋白定位检测系统及应用
CN112661859A (zh) * 2020-12-23 2021-04-16 大连理工大学 一种基于fret的活细胞内pim蛋白活性检测生物探针

Also Published As

Publication number Publication date
CN113234719A (zh) 2021-08-10

Similar Documents

Publication Publication Date Title
US7223556B1 (en) Targeted proteolysis by recruitment to ubiquitin protein ligases
Shen et al. Organelle pH in the Arabidopsis endomembrane system
US7056683B2 (en) Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
CN103298938B (zh) 氧化应激指示物表达用核酸构建物及其应用
Sheu et al. Measurement of intracellular calcium using bioluminescent aequorin expressed in human cells
JP7278634B2 (ja) pH応答性のタンパク質分解プローブ
WO2017144620A1 (en) Light-gated signaling modulation
US20130269046A1 (en) Model for Muscle Atrophy
JP2009153399A (ja) 一分子型リアルタイム生物発光イメージングプローブ
CN113234719B (zh) 检测线粒体膜电势的可遗传荧光探针及其应用
ES2343672T3 (es) Nuevas proteinas transportadoras de aniones organicos.
EP3622292B1 (en) Genetically encoded potassium ion indicators
WO2003008536A2 (en) A system for intracellular process monitoring and in vivo drug screening
US8476484B2 (en) Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
US20180222953A1 (en) Sarcomere biosensor and methods of use thereof
EP3037534A1 (en) Polypeptide exhibiting fluorescent properties, and utilization of same
CN114480494A (zh) 蛋白探针以及其在检测bace1活性中的应用
CN107011444B (zh) 一种筛选hERG钾离子通道激动剂和毒性检测方法
JP4446057B2 (ja) 生体刺激存在下でのmRNAのフレームシフトを利用した蛋白質の発現方法
Frolova et al. Cancer cells targeting with genetically engineered constructs based on a pH-dependent membrane insertion peptide and fluorescent protein
JP2016161420A (ja) 幼若ホルモンセンサー
CN114075297B (zh) 用于检测细胞内fxr蛋白sumo化修饰程度的融合蛋白组、重组载体组、及检测方法
KR20210058889A (ko) C3 사구체병증 모델로서의 보체 인자 h 유전자 녹아웃 래트
US20070042345A1 (en) Polypeptide having intracellular calcium ion indicator function
JP2008224277A (ja) 過酸化水素インディケーター

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Zhang Ziyuan

Inventor after: Huang Zengyi

Inventor after: Wang Hong

Inventor after: Ren Suxia

Inventor after: Cheng Zhi

Inventor after: Liu Deyi

Inventor after: Xu Chaoying

Inventor after: Tan Xin

Inventor after: Tan Li

Inventor before: Huang Zengyi

Inventor before: Zhang Ziyuan

Inventor before: Wang Hong

Inventor before: Ren Suxia

Inventor before: Cheng Zhi

Inventor before: Liu Deyi

Inventor before: Xu Chaoying

Inventor before: Tan Xin

Inventor before: Tan Li

CB03 Change of inventor or designer information